FLEX's buyout of EPC Power strengthens its AI data center infrastructure portfolio, boosting power capabilities ahead of the planned CPI separation in 2027.
Edgewell Personal Care faces persistent top-line contraction, with revenue down 9.1% in the latest quarter and a cumulative decline of 1.34% over the period. Gross margins have been volatile, dipping to 38.1% in 2026Q1, while operating income swung to a loss of $36.3M in 2025Q4, indicating strained profitability.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.72+11.6% vs $0.65 | $570M-0.8% vs $575M |
Q2 2026 May 6, 2026 | $0.60+39.5% vs $0.43 | $520M+0.2% vs $519M |
Q1 2026 Feb 9, 2026 | -$0.16+11.1% vs -$0.18 | $487M+1.8% vs $478M |
Q4 2025 Nov 13, 2025 | $0.68-17.1% vs $0.82 | $537M+10.7% vs $485M |
FLEX's buyout of EPC Power strengthens its AI data center infrastructure portfolio, boosting power capabilities ahead of the planned CPI separation in 2027.
SHELTON, Conn., Oct. 15, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) will report its financial results for the fourth quarter and fiscal year 2026 before the market opens on November 12, 2026.
Wet Ones Clarifies Their Usage with New "Just For Hands" CampaignPR NewswireSHELTON, Conn., Oct. 5, 2026The Brand Takes Over New York City with Playful Reminder
Solesence (NASDAQ: SLSN - Get Free Report) and Edgewell Personal Care (NYSE: EPC - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Analyst Recommendations This is a breakdown
Benchmark EPC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Edgewell Personal Care Company (EPC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $27.99 | $1.29B | -14.00 | -1.34% | -4.55% | -6.27% | 2.2% | |
| $109.33 | $25.91B | 33.68 | 1.57% | 12.41% | 18.21% | 1.08% | |
| $86.68 | $2.01B | 25.12 | -5.23% | 2.77% | 4.18% | 2.15% | |
| $23.84 | $1.63B | 20.24 | 2.28% | 2.73% | 47.41% | 5.07% | |
| $18.28 | $2.3B | -5.23 | -4.26% | -445% | -90.04% | — | |
| $165.40 | $385.15B | 24.84 | 3.26% | 18.23% | 29.42% | 2.55% |
Edgewell Personal Care Company (EPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Edgewell Personal Care Company (EPC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
May 26, 2026·SEC
May 6, 2026·SEC
Get notified when EPC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Edgewell Personal Care Company (EPC) stock FAQ — growth, dividends, profitability & financials explained
Edgewell Personal Care Company (EPC) reported $2.05B in revenue over the trailing twelve months. Revenue was $2.22B in fiscal year 2025. That is 16% more than the $1.92B of fiscal year 1998.
Edgewell Personal Care Company (EPC) revenue fell by 7.0% over the trailing twelve months, compared with the twelve months before.
No. Edgewell Personal Care Company (EPC) reported a net loss of $93.2M over the trailing twelve months.
Yes. Edgewell Personal Care Company (EPC) pays a dividend that yields 2.20% at the current price, a moderate yield.
Edgewell Personal Care Company (EPC) had a return on equity (ROE) of -6.3% over the trailing twelve months. A negative ROE means the company lost money over the period.
Edgewell Personal Care Company (EPC) generated $52.4M in free cash flow over the trailing twelve months.